M. Jane Ehrke
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immunotoxicology and immune responses
- Immune cells in cancer
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Physiology top 5%
- Adenosine and Purinergic Signaling
Papers in
- Immunology 64
- Immunotoxicology and immune responses 29
- Immunotherapy and Immune Responses 28
- T-cell and B-cell Immunology 22
- Immune cells in cancer 11
- Oncology 13
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Enrico Mihich (75 shared papers)Darbie Maccubbin (21 shared papers)Stefan A. Cohen (7 shared papers)Kenneth F. Mace (7 shared papers)Peter Ujházy (15 shared papers)Kazuo Ryoyama (9 shared papers)Erica S. Berleth (12 shared papers)Srđan Verstovšek (12 shared papers)
- Journals
- Cancer Immunology Immunotherapy (7 papers)International Journal of Cancer (5 papers)Immunopharmacology (4 papers)Journal of Leukocyte Biology (2 papers)The Journal of Immunology (2 papers)
- Partner nations
- United StatesCroatiaFrance
In The Last Decade
M. Jane Ehrke
83 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 82
- Immunology 1k
- Physiology 74
- Oncology 296
- Toxicology 40
- Pharmacology 110
Countries citing papers authored by M. Jane Ehrke
This map shows the geographic impact of M. Jane Ehrke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Jane Ehrke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Jane Ehrke more than expected).
Fields of papers citing papers by M. Jane Ehrke
This network shows the impact of papers produced by M. Jane Ehrke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Jane Ehrke. The network helps show where M. Jane Ehrke may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Jane Ehrke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma. | 2006 | 126 |
| 2 | 2003 | 87 | |
| 3 | Effects of anticancer drugs on the immune system in humans. | 1989 | 75 |
| 4 | Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon. | 1987 | 70 |
| 5 | 1996 | 70 | |
| 6 | Tumoricidal activation of murine resident peritoneal macrophages by interleukin 2 and tumor necrosis factor alpha. | 1992 | 61 |
| 7 | Correlation between adriamycin-induced augmentation of interleukin 2 production and of cell-mediated cytotoxicity in mice. | 1986 | 56 |
| 8 | Adriamycin-induced modulation of host defenses in tumor-bearing mice. | 1992 | 56 |
| 9 | Role of tumor necrosis factor in macrophage activation and tumoricidal activity. | 1988 | 55 |
| 10 | 1982 | 53 | |
| 11 | 2006 | 50 | |
| 12 | 2003 | 43 | |
| 13 | Cellular basis for adriamycin-induced augmentation of cell-mediated cytotoxicity in culture. | 1984 | 42 |
| 14 | 1994 | 42 | |
| 15 | 1984 | 40 | |
| 16 | 1994 | 39 | |
| 17 | Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activity. | 1987 | 36 |
| 18 | Alterations in murine host defense functions by adriamycin or liposome-encapsulated adriamycin. | 1988 | 35 |
| 19 | Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages. | 1989 | 34 |
| 20 | Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment. | 1981 | 33 |
About M. Jane Ehrke
M. Jane Ehrke is a scholar working on Immunology, Oncology, Toxicology, Molecular Biology and Pharmacology, having authored 84 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immunotoxicology and immune responses (29 papers), Immunotherapy and Immune Responses (28 papers), T-cell and B-cell Immunology (22 papers), Immune cells in cancer (11 papers), Cell death mechanisms and regulation (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Immunology (1k citations), Physiology (74 citations), Oncology (296 citations), Toxicology (40 citations) and Pharmacology (110 citations). M. Jane Ehrke has collaborated with scholars based in United States, Croatia and France. Frequent co-authors include Enrico Mihich, Darbie Maccubbin, Stefan A. Cohen, Kenneth F. Mace, Peter Ujházy, Kazuo Ryoyama, Erica S. Berleth, Srđan Verstovšek, Cheryl Eppolito and David Berd. Their work appears in journals such as Cancer Immunology Immunotherapy, International Journal of Cancer, Immunopharmacology, Journal of Leukocyte Biology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.